CD4 and neoplasm: There was a significant increase in the number of CD4+ T cells and Tregs in the IL-6-depleted tumors indicating that the tumor cell derived increase in IL-6 secretion following Kindlin-1 loss can drive changes in Tregs in vivo (Figure 7A).